<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel><title>Andrés</title>
<link>https://test.newsroom.notified.com/intrado-2</link>
<description>Andrés  - PressRelease</description>
<item>
  <title>test</title>
  <link>https://test.newsroom.notified.com/intrado-2/posts/pressreleases/test-3</link>
  <description>testar</description>
  <guid isPermaLink="false">https://test.newsroom.notified.com/intrado-2/posts/pressreleases/test-3</guid>
  <pubDate>Thu, 01 Feb 2024 09:23:00 GMT</pubDate>
</item>
<item>
  <title>Checking X logo</title>
  <link>https://test.newsroom.notified.com/intrado-2/posts/pressreleases/checking-x-logo</link>
  <description>test</description>
  <guid isPermaLink="false">https://test.newsroom.notified.com/intrado-2/posts/pressreleases/checking-x-logo</guid>
  <pubDate>Thu, 01 Feb 2024 09:20:09 GMT</pubDate>
</item>
<item>
  <title>News without recipients</title>
  <link>https://test.newsroom.notified.com/intrado-2/posts/pressreleases/news-without-recipients</link>
  <description>PR-5536</description>
  <guid isPermaLink="false">https://test.newsroom.notified.com/intrado-2/posts/pressreleases/news-without-recipients</guid>
  <pubDate>Mon, 20 Nov 2023 12:40:58 GMT</pubDate>
</item>
<item>
  <title>Testing webp images</title>
  <link>https://test.newsroom.notified.com/intrado-2/posts/pressreleases/testing-webp-images-1</link>
  <description>Testing webp images</description>
  <guid isPermaLink="false">https://test.newsroom.notified.com/intrado-2/posts/pressreleases/testing-webp-images-1</guid>
  <pubDate>Tue, 09 May 2023 14:15:46 GMT</pubDate>
</item>
<item>
  <title>Testing webp images</title>
  <link>https://test.newsroom.notified.com/intrado-2/posts/pressreleases/testing-webp-images</link>
  <description>testar</description>
  <guid isPermaLink="false">https://test.newsroom.notified.com/intrado-2/posts/pressreleases/testing-webp-images</guid>
  <pubDate>Wed, 12 Apr 2023 06:43:50 GMT</pubDate>
  <enclosure type="image/jpeg" length="5200" url="https://cdn.filestackcontent.com/auto_image/8G8HxFKkRtCTlPuhlGBl" />
</item>
<item>
  <title>Geocann and Sunderstorm expand KANHA brand internationally, becoming the first North American cannabis edibles brand to launch in Asia</title>
  <link>https://test.newsroom.notified.com/intrado-2/posts/pressreleases/geocann-and-sunderstorm-expand-kanha-brand-in</link>
  <description>Responding to the global market demand for fast-acting and high bioavailable cannabis edible products, Sunderstorm’s KANHA Nano gummies feature the science-backed VESIsorb® delivery system technology</description>
  <guid isPermaLink="false">https://test.newsroom.notified.com/intrado-2/posts/pressreleases/geocann-and-sunderstorm-expand-kanha-brand-in</guid>
  <pubDate>Thu, 08 Dec 2022 17:45:00 GMT</pubDate>
  <enclosure type="image/jpeg" length="5200" url="https://cdn.filestackcontent.com/sE3pKJ66RqBbNeIIHQIA" />
</item>
<item>
  <title>Geocann expands cannabis scientific research leadership with first human β-caryophyllene (BCP) published study demonstrating the safety and performance of novel formulation</title>
  <link>https://test.newsroom.notified.com/intrado-2/posts/pressreleases/geocann-expands-cannabis-scientific-research</link>
  <description>VESIsorb® drug delivery technology-based formulation dramatically improves all measured pharmacokinetic (PK) parameters of BCP compared to BCP neat oil.</description>
  <guid isPermaLink="false">https://test.newsroom.notified.com/intrado-2/posts/pressreleases/geocann-expands-cannabis-scientific-research</guid>
  <pubDate>Wed, 09 Nov 2022 20:15:00 GMT</pubDate>
</item>
<item>
  <title>Test</title>
  <link>https://test.newsroom.notified.com/intrado-2/posts/pressreleases/test-2</link>
  <description>Testar efter uppgradering av Newtonsoft.</description>
  <guid isPermaLink="false">https://test.newsroom.notified.com/intrado-2/posts/pressreleases/test-2</guid>
  <pubDate>Fri, 30 Sep 2022 09:03:10 GMT</pubDate>
</item>
<item>
  <title>Testar</title>
  <link>https://test.newsroom.notified.com/intrado-2/posts/pressreleases/testar-2</link>
  <description>test</description>
  <guid isPermaLink="false">https://test.newsroom.notified.com/intrado-2/posts/pressreleases/testar-2</guid>
  <pubDate>Thu, 25 Aug 2022 08:47:48 GMT</pubDate>
</item>
<item>
  <title>Related content links</title>
  <link>https://test.newsroom.notified.com/intrado-2/posts/pressreleases/related-content-links</link>
  <description>testar</description>
  <guid isPermaLink="false">https://test.newsroom.notified.com/intrado-2/posts/pressreleases/related-content-links</guid>
  <pubDate>Thu, 25 Aug 2022 08:45:41 GMT</pubDate>
</item>
<item>
  <title>Testing presskit</title>
  <link>https://test.newsroom.notified.com/intrado-2/posts/pressreleases/testing-presskit</link>
  <description>Testing presskit</description>
  <guid isPermaLink="false">https://test.newsroom.notified.com/intrado-2/posts/pressreleases/testing-presskit</guid>
  <pubDate>Tue, 31 May 2022 07:54:51 GMT</pubDate>
</item>
<item>
  <title>Geocann and Averix Bio form a strategic partnership to supply the global marketplace with pharmaceutical API phytocannabinoid ingredients formulated with a clinically proven drug delivery system technology</title>
  <link>https://test.newsroom.notified.com/intrado-2/posts/pressreleases/geocann-and-averix-bio-form-a-strategic-partn</link>
  <description>The partnership will allow Geocann to have the exclusive distribution rights of Averix Bio phytocannabinoid ingredients in the rapidly evolving South American marketplace where they will offer pharmaceutical API starting materials, available as either stand-alone ingredients or clinically proven VESIsorb® formulations.</description>
  <guid isPermaLink="false">https://test.newsroom.notified.com/intrado-2/posts/pressreleases/geocann-and-averix-bio-form-a-strategic-partn</guid>
  <pubDate>Wed, 13 Apr 2022 13:04:00 GMT</pubDate>
  <enclosure type="image/jpeg" length="5200" url="https://cdn.filestackcontent.com/lcYdHtkYQRGHuxsa6aGo" />
</item>
<item>
  <title>Theralogix is first to launch an NSF International certified CBD softgel powered by the clinically proven VESIsorb® technology</title>
  <link>https://test.newsroom.notified.com/intrado-2/posts/pressreleases/theralogix-is-first-to-launch-an-nsf-internat</link>
  <description>Theralogix, a leading healthcare professional brand, successfully completed the rigorous NSF testing and certification process for its new CBD product, TheraHemp, to ensure accurate potency and purity</description>
  <guid isPermaLink="false">https://test.newsroom.notified.com/intrado-2/posts/pressreleases/theralogix-is-first-to-launch-an-nsf-internat</guid>
  <pubDate>Tue, 12 Apr 2022 03:19:33 GMT</pubDate>
  <enclosure type="image/jpeg" length="5200" url="https://cdn.filestackcontent.com/ulFrMsUATbpRscr7ltba" />
</item>
<item>
  <title>test</title>
  <link>https://test.newsroom.notified.com/intrado-2/posts/pressreleases/test</link>
  <description>test</description>
  <guid isPermaLink="false">https://test.newsroom.notified.com/intrado-2/posts/pressreleases/test</guid>
  <pubDate>Wed, 06 Apr 2022 20:09:51 GMT</pubDate>
</item>
<item>
  <title>Testar larm vid misslyckad schemalagd release</title>
  <link>https://test.newsroom.notified.com/intrado-2/posts/pressreleases/testar-larm-vid-misslyckad-schemalagd-release</link>
  <description>Testar larm vid misslyckad schemalagd release.</description>
  <guid isPermaLink="false">https://test.newsroom.notified.com/intrado-2/posts/pressreleases/testar-larm-vid-misslyckad-schemalagd-release</guid>
  <pubDate>Tue, 05 Apr 2022 08:10:00 GMT</pubDate>
  <enclosure type="image/jpeg" length="5200" url="https://cdn.filestackcontent.com/UK5Xnv4qRpmg4ueG9gHZ" />
</item>
<item>
  <title>testar</title>
  <link>https://test.newsroom.notified.com/intrado-2/posts/pressreleases/testar-1</link>
  <description>test</description>
  <guid isPermaLink="false">https://test.newsroom.notified.com/intrado-2/posts/pressreleases/testar-1</guid>
  <pubDate>Tue, 08 Mar 2022 14:26:38 GMT</pubDate>
</item>
<item>
  <title>Testing license for EF Extensions from ZZZ</title>
  <link>https://test.newsroom.notified.com/intrado-2/posts/pressreleases/testing-license-for-ef-extensions-from-zzz</link>
  <description>Testing license for EF Extensions from ZZZ</description>
  <guid isPermaLink="false">https://test.newsroom.notified.com/intrado-2/posts/pressreleases/testing-license-for-ef-extensions-from-zzz</guid>
  <pubDate>Tue, 18 Jan 2022 09:18:27 GMT</pubDate>
</item>
<item>
  <title>Scheduled publish at 2021-06-14 15:20</title>
  <link>https://test.newsroom.notified.com/intrado-2/posts/pressreleases/scheduled-publish-at-2021-06-14-1520</link>
  <description>Scheduled publish at 2021-06-14 15:20</description>
  <guid isPermaLink="false">https://test.newsroom.notified.com/intrado-2/posts/pressreleases/scheduled-publish-at-2021-06-14-1520</guid>
  <pubDate>Mon, 14 Jun 2021 13:20:00 GMT</pubDate>
</item>
<item>
  <title>Press release in K8S</title>
  <link>https://test.newsroom.notified.com/intrado-2/posts/pressreleases/press-release-in-k8s</link>
  <description>Press release in K8S</description>
  <guid isPermaLink="false">https://test.newsroom.notified.com/intrado-2/posts/pressreleases/press-release-in-k8s</guid>
  <pubDate>Tue, 08 Jun 2021 09:16:43 GMT</pubDate>
</item>
<item>
  <title>testar</title>
  <link>https://test.newsroom.notified.com/intrado-2/posts/pressreleases/testar</link>
  <description>testar</description>
  <guid isPermaLink="false">https://test.newsroom.notified.com/intrado-2/posts/pressreleases/testar</guid>
  <pubDate>Mon, 07 Jun 2021 16:12:11 GMT</pubDate>
</item>
<item>
  <title>Nokia achieves 5G speed world record with Turk Telekom</title>
  <link>https://test.newsroom.notified.com/intrado-2/posts/pressreleases/nokia-achieves-5g-speed-world-record-with-tur-1</link>
  <description> Press ReleaseNokia achieves 5G speed world record with Turk Telekom</description>
  <guid isPermaLink="false">https://test.newsroom.notified.com/intrado-2/posts/pressreleases/nokia-achieves-5g-speed-world-record-with-tur-1</guid>
  <pubDate>Wed, 26 May 2021 10:29:28 GMT</pubDate>
</item>
<item>
  <title>Geocann and Pathway Health form a strategic partnership to supply VESIsorb® formulated medical cannabis products to leading retail pharmacy brands throughout Canada</title>
  <link>https://test.newsroom.notified.com/intrado-2/posts/pressreleases/geocann-and-pathway-health-form-a-strategic-p-1</link>
  <description>The partnership will allow Pathway Health to have exclusive distribution of a robust portfolio of proprietary formulations that are co-branded through its retail pharmacy partners and powered by the science-backed and multi-patented VESIsorb® drug delivery system for optimal bioavailability and maximum therapeutic benefits.</description>
  <guid isPermaLink="false">https://test.newsroom.notified.com/intrado-2/posts/pressreleases/geocann-and-pathway-health-form-a-strategic-p-1</guid>
  <pubDate>Wed, 27 Jan 2021 14:45:00 GMT</pubDate>
</item>
<item>
  <title>Geocann reinforces its commitment to pioneering new clinical studies with the addition of internationally recognized medical researcher</title>
  <link>https://test.newsroom.notified.com/intrado-2/posts/pressreleases/geocann-reinforces-its-commitment-to-pioneeri-1</link>
  <description>Michael Davidson, M.D., joins Geocann as Head of Innovation, Technology, and Clinical Research to leverage his successful track record in both pharmaceutical and nutritional clinical trials that will expand Geocann’s global leadership position in the commercialization of science-backed and patent-protected formulations.</description>
  <guid isPermaLink="false">https://test.newsroom.notified.com/intrado-2/posts/pressreleases/geocann-reinforces-its-commitment-to-pioneeri-1</guid>
  <pubDate>Thu, 12 Nov 2020 16:10:00 GMT</pubDate>
  <enclosure type="image/jpeg" length="5200" url="https://cdn.filestackcontent.com/iOSd69AFQNuGYdLPBy4Q" />
</item>
<item>
  <title>Nestlé Health Science expands distribution of hemp products formulated with VESIsorb® into Europe under industry-leading brand, Pure Encapsulations®</title>
  <link>https://test.newsroom.notified.com/intrado-2/posts/pressreleases/nestle-health-science-expands-distribution-of</link>
  <description>The company is leveraging a peer-reviewed, published CBD study and new product safety data from Geocann to build momentum after successful product launches in the U.S.</description>
  <guid isPermaLink="false">https://test.newsroom.notified.com/intrado-2/posts/pressreleases/nestle-health-science-expands-distribution-of</guid>
  <pubDate>Fri, 11 Sep 2020 12:45:00 GMT</pubDate>
  <enclosure type="image/jpeg" length="5200" url="https://cdn.filestackcontent.com/3YSV5AfeRXKNfiiryWwJ" />
</item>
<item>
  <title>Geocann and Sunderstorm enter agreement to expand California leadership position across the U.S. with VESIsorb® formulated cannabis products</title>
  <link>https://test.newsroom.notified.com/intrado-2/posts/pressreleases/geocann-and-sunderstorm-enter-agreement-to-ex</link>
  <description>Geocann will provide semi-exclusive supply and distribution rights of patented drug delivery system technologies to protect Sunderstorm’s place as the number one selling edible gummy brand in California with additional support for national expansion in key states</description>
  <guid isPermaLink="false">https://test.newsroom.notified.com/intrado-2/posts/pressreleases/geocann-and-sunderstorm-enter-agreement-to-ex</guid>
  <pubDate>Tue, 01 Sep 2020 15:34:58 GMT</pubDate>
  <enclosure type="image/jpeg" length="5200" url="https://cdn.filestackcontent.com/R3ZuPW2DQP5eMSRrivyz" />
</item>
<item>
  <title>Geocann inks supply and distribution agreement with Opticann, a new U.S.-based company founded by former MedReleaf executives</title>
  <link>https://test.newsroom.notified.com/intrado-2/posts/pressreleases/geocann-inks-supply-and-distribution-agreemen</link>
  <description>Geocann will provide exclusive distribution rights to market a select portfolio of VESIsorb® formulated oral and topical CBD and CBG products to major U.S. retailers</description>
  <guid isPermaLink="false">https://test.newsroom.notified.com/intrado-2/posts/pressreleases/geocann-inks-supply-and-distribution-agreemen</guid>
  <pubDate>Thu, 06 Aug 2020 20:00:00 GMT</pubDate>
  <enclosure type="image/jpeg" length="5200" url="https://cdn.filestackcontent.com/G4b7D0x5SsW4Tzr4det5" />
</item>
<item>
  <title>Geocann introduces the industry’s first 4-in-1 immunity support formulation utilizing the patented VESIsorb® drug delivery system</title>
  <link>https://test.newsroom.notified.com/intrado-2/posts/pressreleases/geocann-introduces-the-industrys-first-4-in-1</link>
  <description>Science-backed ingredients – curcumin, cannabidiol (CBD), beta-caryophyllene (BCP), and vitamin D3 – have been successfully formulated with an innovative drug delivery technology in a soft gel capsule for optimized absorption, bioavailability and therapeutic benefits.</description>
  <guid isPermaLink="false">https://test.newsroom.notified.com/intrado-2/posts/pressreleases/geocann-introduces-the-industrys-first-4-in-1</guid>
  <pubDate>Thu, 30 Jul 2020 23:00:00 GMT</pubDate>
  <enclosure type="image/jpeg" length="5200" url="https://cdn.filestackcontent.com/DHowOBshQxWyAmIdPjTk" />
</item>
<item>
  <title>Duis aute irure dolor in reprehenderit</title>
  <link>https://test.newsroom.notified.com/intrado-2/posts/pressreleases/duis-aute-irure-dolor-in-reprehenderit</link>
  <description>Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.</description>
  <guid isPermaLink="false">https://test.newsroom.notified.com/intrado-2/posts/pressreleases/duis-aute-irure-dolor-in-reprehenderit</guid>
  <pubDate>Thu, 04 Jun 2020 09:05:23 GMT</pubDate>
</item>
<item>
  <title>Nemo enim ipsam voluptatem quia voluptas </title>
  <link>https://test.newsroom.notified.com/intrado-2/posts/pressreleases/nemo-enim-ipsam-voluptatem-quia-voluptas</link>
  <description>Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.</description>
  <guid isPermaLink="false">https://test.newsroom.notified.com/intrado-2/posts/pressreleases/nemo-enim-ipsam-voluptatem-quia-voluptas</guid>
  <pubDate>Thu, 04 Jun 2020 09:05:23 GMT</pubDate>
</item>
<item>
  <title>At vero eos et accusamus et iusto odio dignissimos</title>
  <link>https://test.newsroom.notified.com/intrado-2/posts/pressreleases/at-vero-eos-et-accusamus-et-iusto-odio-dignis</link>
  <description>Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.</description>
  <guid isPermaLink="false">https://test.newsroom.notified.com/intrado-2/posts/pressreleases/at-vero-eos-et-accusamus-et-iusto-odio-dignis</guid>
  <pubDate>Thu, 04 Jun 2020 09:05:23 GMT</pubDate>
</item>
<item>
  <title>Lorem ipsum dolor sit amet</title>
  <link>https://test.newsroom.notified.com/intrado-2/posts/pressreleases/lorem-ipsum-dolor-sit-amet</link>
  <description>Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.</description>
  <guid isPermaLink="false">https://test.newsroom.notified.com/intrado-2/posts/pressreleases/lorem-ipsum-dolor-sit-amet</guid>
  <pubDate>Thu, 04 Jun 2020 09:05:23 GMT</pubDate>
</item>
<item>
  <title>Geocann’s VESIsorb® cannabidiol formulation delivers superior pharmacokinetic performance in published study</title>
  <link>https://test.newsroom.notified.com/intrado-2/posts/pressreleases/geocanns-vesisorb-cannabidiol-formulation-del</link>
  <description>The innovative, patent-protected, VESIsorb® drug delivery system provides the needed scientific evidence that supports improved cannabidiol (CBD) bioavailability in seminal study.</description>
  <guid isPermaLink="false">https://test.newsroom.notified.com/intrado-2/posts/pressreleases/geocanns-vesisorb-cannabidiol-formulation-del</guid>
  <pubDate>Tue, 14 Apr 2020 16:00:00 GMT</pubDate>
  <enclosure type="image/jpeg" length="5200" url="https://cdn.filestackcontent.com/UFGM4M7vRhywQ4oqsMd2" />
</item>
<item>
  <title>Geocann is first-to-market introducing cannabigerol (CBG) formulations utilizing the VESIsorb® drug delivery system</title>
  <link>https://test.newsroom.notified.com/intrado-2/posts/pressreleases/geocann-is-first-to-market-introducing-cannab</link>
  <description>CBG is among the many emerging cannabinoids and terpenes that Geocann is committed to pioneering through its technical formulation expertise and global distribution infrastructure.</description>
  <guid isPermaLink="false">https://test.newsroom.notified.com/intrado-2/posts/pressreleases/geocann-is-first-to-market-introducing-cannab</guid>
  <pubDate>Fri, 23 Aug 2019 15:00:00 GMT</pubDate>
  <enclosure type="image/jpeg" length="5200" url="https://cdn.filestackcontent.com/G4b7D0x5SsW4Tzr4det5" />
</item>
<item>
  <title>Geocann Appoints Medical and Scientific Advisory Board to Expand Its Leadership Position in Research and Innovation</title>
  <link>https://test.newsroom.notified.com/intrado-2/posts/pressreleases/geocann-appoints-medical-and-scientific-advis</link>
  <description>The prestigious group is comprised of a multidisciplinary collective with decades of well-documented and published work as well as prominent careers focused on advancing the therapeutic benefits of science-backed natural ingredients, like cannabinoids and terpenes.</description>
  <guid isPermaLink="false">https://test.newsroom.notified.com/intrado-2/posts/pressreleases/geocann-appoints-medical-and-scientific-advis</guid>
  <pubDate>Thu, 25 Jul 2019 23:00:00 GMT</pubDate>
</item>
<item>
  <title>Geocann Launches Patent-Protected Cannabis Formulations For Rapid Uptake Edible and Beverage Products</title>
  <link>https://test.newsroom.notified.com/intrado-2/posts/pressreleases/geocann-launches-patent-protected-cannabis-fo</link>
  <description>Industry-leading solution provider addresses the need to formulate cannabinoids with fast-acting and predictable onset, offering leading brands the ability to deliver the safest and most efficacious food and beverage products to cannabis consumers.</description>
  <guid isPermaLink="false">https://test.newsroom.notified.com/intrado-2/posts/pressreleases/geocann-launches-patent-protected-cannabis-fo</guid>
  <pubDate>Tue, 23 Jul 2019 21:30:00 GMT</pubDate>
</item></channel>
</rss>